Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Imprimis Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

28 Feb 2015 Reuters Investment Profile 12 $20.00

IMPRIMIS PHARMACEUTICALS INC (IMMY) 12-months forecast

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

28 Feb 2015 Pechala's Reports 1 $15.00

IMPRIMIS PHARMACEUTICALS INC (IMMY) - REPORT FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

28 Feb 2015 Pechala's Reports 1 $25.00

ValuEngine Industry Report for Medical Products(IMMY)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

26 Feb 2015 ValuEngine, Inc. 10 $49.00

ValuEngine Rating and Forecast Report for IMMY

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

23 Feb 2015 ValuEngine, Inc. 11 $25.00

Wright Investors Service Comprehensive Report for Imprimis Pharmaceuticals Incorporated

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

22 Feb 2015 Wright Reports 55 $75.00

TheStreet.com Ratings Stock Report For: IMPRIMIS PHARMACEUTICALS INC (IMMY)

15 Feb 2015 TheStreet.com Ratings 5 $10.00

TheStreet.com Ratings Stock Report For: IMPRIMIS PHARMACEUTICALS INC (IMMY)

08 Feb 2015 TheStreet.com Ratings 5 $10.00

ValuEngine Rating and Forecast Report for IMMY

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

02 Feb 2015 ValuEngine, Inc. 11 $25.00

TheStreet.com Ratings Stock Report For: IMPRIMIS PHARMACEUTICALS INC (IMMY)

01 Feb 2015 TheStreet.com Ratings 5 $10.00